Keyphrases
Taiwan
100%
Hospitalization
100%
Heart Failure Treatment
100%
Care Groups
57%
Heart Failure Trials
57%
Heart Failure Hospitalization
42%
Heart Failure
28%
All-cause Mortality
28%
Heart Failure Therapy
28%
Usual Care
28%
N-terminal Pro-brain Natriuretic Peptide (NT-proBNP)
28%
Blood Pressure
14%
Heart Failure with Preserved Ejection Fraction (HFpEF)
14%
Acute Heart Failure
14%
Left Ventricular Ejection Fraction
14%
Taiwanese
14%
Data Combination
14%
Heart Rate
14%
Failure Study
14%
At Discharge
14%
Real-world Practice
14%
Rapid Optimization
14%
Tolerability
14%
Taiwan Society of Cardiology
14%
Guideline-directed Medical Therapy
14%
Angiotensin Receptor-neprilysin Inhibitor
14%
Evidence-based Treatment
14%
Treatment Gap
14%
Heart Failure Guidelines
14%
Real-life Cohort
14%
Medicine and Dentistry
Congestive Heart Failure
100%
Care Group
30%
All Cause Mortality
15%
Titrimetry
15%
Blood Pressure
7%
Heart Failure with Reduced Ejection Fraction
7%
Cohort Analysis
7%
Acute Decompensated Heart Failure
7%
Mortality Rate
7%
Amino Terminal Sequence
7%
Combination Therapy
7%
Heart Left Ventricle Ejection Fraction
7%
Brain Natriuretic Peptide
7%
Cardiology
7%
Angiotensin Receptor
7%
Enkephalinase Inhibitor
7%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
All Cause Mortality
15%
Acute Heart Failure
7%
Combination Therapy
7%
Cohort Study
7%
Mortality Rate
7%
Brain Natriuretic Peptide
7%
Tolerability
7%
Angiotensin Receptor
7%
Enkephalinase Inhibitor
7%
Heart Failure with Reduced Ejection Fraction
7%